|
Order-No.:
E.22(15)Med./74/Pt.
Dated 6.3.2000
Whereas, it was brought to the
notice of the State Government that high profits in
pharmaceutical industry has led to a large number of
drugs and medicinal products under various brand names
and number of them have been reported to be irrational
combinations as per WHO criteria. As a first step
towards promotion of rational use of drugs on the basis
of efficacy, safety, suitability and cost effectiveness,
the State Government had constituted an Essential drug
List Committee (EDLC) comprising of highly qualified
professionals and clinical specialists of various
disciplines to prepare an Essential Drug List (EDL) for
the State of Rajasthan.
And, whereas this EDLC circulated the National
Essential Drug List along with WHO criteria for
selection of Essential drugs amongst all the principal
user-institutions viz. Principals & Controllers of
all six Medical Colleges of the state, all Directors of
Medical health Services, Rajasthan running different
national programmes with a request to examine the
National Essential Drug List in their respective
institutions looking into the health needs of the people
providing treatment facilities at different levels of
State health care institutions and send their
suggestions and comments in this regard. After receiving
the observations and comments of these Principal use
institutions, the Essential Drug List committee
deliberated and finalised the Essential Drug List (EDL)
for the State of Rajasthan availing the expertise of a
WHO representative as the member of the EDLC and
submitted to the Government.
The State Government is pleased to accept the
report of the EDLC and hereby declare it as Rajasthan
State Essential List (RSEDL-2000) for the State of
Rajasthan (Annexure-I) with the following Guidelines.
1.
The doctors of the state working under Government
shall prescribe and use medicines out of the RSEDL only
as far as possible. Deviations in prescription outside
the RSEDL would be subject to scrutiny by an
“Authorised Medical Authority” to be constituted by
the Government.
2.
The EDL would serve as a positive list for the
public servants and pensioners. Therefore, medicines to
these categories would be reimbursable only from EDL.
Medicare Relief Card holders would also be prescribed
medicines only out of this list claiming reimbursement
of Medicare care. This would prevent unnecessary
prescribing and save money to Government exchequer.
However, in case of severe/chronic illness and life
threatening situations supported by the recommendations
of “
Authorised medical Authority” to be notified
separately, the reimbursement to these categories
outside the RSEDL could be considered by the Government.
3.
Procurement of drugs and medicines in government
hospitals and institutions would continue to be on the
basis of existing drug list of the government as this is
reported to be sufficient to take care of 90-95% cases
of illness. Broadly, 75% of the budget of a hospital
should be spent for procuring medicines from the list.
Remaining 25% budget should be spent to procure
medicines from EDL. This ratio of expenditure could be
relaxed by the government on receipt of specific
proposals from an institution through HOD with this
recommendation. Store Purchase Organization of Medical
& Health Department would circulate the approved
rate contract for all medicines in the EDL on the basis
of which the CM&HO’s. PMO’s and Suptds, Medical
Collage Hospitals would procure medicines as per their
demand.
4.
After the approved rate contract is circulated to
all concerned. It would be the responsibility of the
in-charge of the medical institution to ensure that
medicines in the approved rate contract are available in
the hospital and dispensed on priority. To the following
categories free of cost:
I.
Medicare Relief Card holders
II.
Emergency cases
III.
Other extreme poor categories like destitute,
beggars, orphans, senior citizens and widows unable to
afford treatment costs. Decision on this would be taken
discretely by in-charge of the hospital and in this
absence by another doctor authorised by him for this
purpose. Since budget is limited it is expected to use
the discretion with utmost caution.
A
separate account of drug dispensation to each of the
above category would be maintained Separate Drug
dispensation counters be opened in each Hospital.
5.
The RSEDL is not static and would be periodically
revised by EDLC, which may be constituted by the
Government from time to time to cope up with the changed
environment and rational need of the prescribing.
6.
Principals & Superintendents of Medical
Collages would ensure that teaching of the Essential
Drug List is included in the curriculum of graduate and
post graduate Medical students and adequate time is
provided for its teaching.
7.
All in-charge of the Government hospitals.
Principals and Superintendents of Medical Collages.
Directors of Medical Health Services would take
immediate steps to ensure compliance of the EDL in their
hospitals. They should convene meeting of the doctors
and sensitise them on use of EDL. Similarly, they should
also take steps to sensitise the Private Medical
Practitioners on the use of this list for the general
benefit of the public.
This order issues with the
concurrence of FD vide ID No. 684/Fs/2000 dated
24.2.2000
1)
Drugs marked with an asterisk (*) are to be
considered as complimentary drugs, i.e.Those that are
used if the other drugs there are not available or they
are required for specific patients, situations or
locations for valid reasons.
2)
The names of drugs are followed by the letters
given below to indicate their need at various levels of
medical care:
P-
Primary Health Care
S-
Secondary Health Care
T-
Tertiary Health Care
U-
Universal
3)
Although the drugs are listed by their peu
categories, these are not necessarily meant to be use as
prescribing guidelines. A drug that may deserve to be
included in a particular category may not be found
there, as it may already be included in another
category.
Essential
Drugs List
|
S.No.
|
Drugs
Name |
Type |
|
1. Anaesthetics
|
|
|
1.1 Gen. Anaesthetics
& Oxygen
|
|
|
|
Ether
Halothane
Isoflurane*
Ketamine
Nitrous Oxide
Oxygen
Thiopental sodium
|
S, T
S, T
S, T
S, T
S, T
U
S, T
|
|
1.2
|
Local Anaesthetics
|
|
|
|
Bupivacaine HCl
Ethyl Chloride
Ligncocaine
|
U
U
T
|
|
1.3
|
Preop. Medication &
Sedation for short term Procedures
|
|
|
Atropine Sulphate
Diazepam
Morphine
Promethazine
Glycopyrrolate
|
U
U
S, T
U
T
|
|
2.
|
Analgesics, Antipyretics
& ASAIDS and Drugs used to treat Gout
|
|
2.1
|
Non-opioid Analgesics
|
|
|
|
Acetyl Salicylic Acid
Allopurinol
Diclofenac
Ibuprofen
Paracetamol
|
U
S, T
U
U
U
|
|
2.2
|
Opioid Analgesics
|
|
|
|
Pethidine (HCl)
Pentazocine
|
S, T
S, T
|
|
3.
|
Anti Allergics & Drugs
used in Anaphylaxis
|
|
|
Chlorpheniramine
Pheniramine
Cetrizine
Dexamethasone
Epinephrine
Hydrocortisone Sodium Succinate
Prednisolone
Promethazine
|
U
U
U
U
U
P, S, T
S, T
U
|
|
4.
|
Antidotes and other
Substances used in Poisoning
|
|
4.1
|
Non specific
|
|
|
|
Activated charcoal
Atropine
|
U
U
|
|
4.2
|
Specific
|
|
|
|
Anti snake venom
Deferoxamine
Methylthioninium Chloride (Methylene Blue)
Naloxone*
Pralidoxime (2-PAM)
Sodium Nitrate*
Sodium Thiosulphate*
Penicillamine*
|
U
S, T
S, T
S, T
U
S, T
S, T
S, T
|
|
5.
|
Anticonvulsants
|
|
|
|
Carbamazepine
Clonazepam
Diazepam
Phenobarbital
Phenytoin Sodium
Sodium Valproate
|
U
T
U
U
U
U
|
|
6.
|
Anti-Infective Drugs
|
|
|
6.1.1
|
Intestinal Anthelmintics
|
|
|
|
Albendazole
Niclosamide
|
U
S, T
|
|
6.1.2
|
Antifilarials
|
|
|
|
Diethylcarbamazine
|
U
|
|
6.2
|
Antifilarials
|
|
|
6.2.1
|
Penicillin’s
|
|
|
|
Amoxycillin
Amoxycillin + Clavulanic Acid
Ampicillin
Cloxacillin
Benzathine Benzyl penicillin
Benzyl Penicillin
Procaine Benzyl penicillin
|
U
T
U
U
U
U
U
|
|
6.2.2
|
Other Antibacterial
|
|
|
|
Amikacin*
Cephalexin*
Chloramphenicol
Ciprofloxacin
Co. Trimoxazole (Trimethoprim Sulphamethoxazole)
Doxycycline
Erythromycin
Gentamycin
Metronidazole
Nalidixic Acid
Nitrofurantion
Norfloxacin
Tetracycline
Reserve Anti-Bacterial Amoxycillin + Clavulanic
Acid
Cefototaxime
Cefazolin
Ceftriaxone
|
S, T
U
S, T
S, T
U
U
U
S, T
U
U
U
S, T
U
T
T
T
T
|
|
6.2.3
|
Anti-Leprosy
|
|
|
|
Clofazimine
Dapsone
Rifampicin
|
T
U
U
|
|
6.2.4
|
Anti-Tuberculosis
|
|
|
|
Ethambutol
Isoniazid
Pyrazinamide
Rifampicin
Streptomycin
PAS
Rifampicin + Isoniazid
Rifampicin + Isoniazid + Pyrazinamide
|
U
U
U
U
U
U
U
U
|
|
6.3
|
Anti-Fungals
|
|
|
|
Amphotericin
Griseofulvin
Ketoconazole
Nystatin
Clotrimazole
|
T
S, T
S, T
S, T
P
|
|
6.4
|
Antiprotozoal Drugs
|
|
|
6.4.1
|
Antiamoebic &
Antigiardiasis
|
|
|
|
Diloxanide Furoate
Metronidazole
Tinidazole
|
S, T
U
U
|
|
6.4.2
|
Antileishmaniasis Drugs
|
|
|
|
Pentamidine
Sodium Stilbogluconate
|
S, T
S, T
|
|
6.4.3
|
Antimalarial Drugs
|
|
|
|
Chloroquine
Primaquine
Quinine
Sulfadoxine + Pyrimethamine
Artesunate
Mefloquine
|
U
U
U
U
S, T
S, T
|
|
6.5
|
Anti-Viral Drugs
|
|
|
|
Acyclovir*
|
S, T
|
|
7.
|
Antimigraine Drugs
|
|
|
7.1
|
For treatment of acute attack
|
|
|
|
Acetyl Salicylic Acid
Dihydro Ergotamine
Paracetamol
|
U
S, T
U
|
|
7.2
|
For Prophylaxis
|
|
|
|
Propranolol
|
U
|
|
8.
|
Antineoplastic and
Immunosuppressant, These Drugs are Specialized and
Drugs and Drugs used in Palliative Toxic Drugs be
Purchased only Care when necessary
|
|
8.1
|
Immunosuppressant
|
|
|
|
Azathioprine*
Cyclosporine*
|
T
T
|
|
8.2
|
Cytotoxic Drugs
|
|
|
|
Bleomycin*
Actinomycin D*
L-Asparaginase*
Busulfan*
Cisplatin*
Cyclophosphamide*
Cytosine Arabinoside*
Danazol*
Doxorubicin*
Etoposide*
Folinic Acid*
Fluorouracil*
Melphalan*
Mercaptopurine*
Methotrexate*
Mitomycin-C
Procarbazine*
Vincristine*
Vinblastine*
Hydroxyurea*
Chlorambucil*
Flutamide*
|
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
T
|
|
8.3
|
Hormones and Antihormones
|
|
|
|
Prednisolone
Tamoxifen
|
S, T
T
|
|
9.
|
Anti-Parkinsonism Drugs
|
|
|
|
Trihexyphenidyl
Biperiden*
Levodopa/ Carbidopa
|
U
S, T
U
|
|
10.
|
Drugs affecting the Blood
|
|
|
10.1
|
Antianemia drugs
|
|
|
|
Ferrous salt
Folic Acid
Iron Folic Acid (Large)
Folic Acid+ exsiccated ferrous sulph.
Iron Folic Acid (Small)
Folic Acid + exsiccated ferrous sulph.
Iron Dextran
Vitamin B12
|
U
U
U
U
U
U
|
|
10.2
|
Drugs affecting coagulation
|
|
|
|
Heparin Sodium
Protamine Sulfate
Vitamin K
Acenocoumarol*
Warfarin
|
S, T
S, T
S, T
S, T
S, T
|
|
11.
|
Blood Products and Plasma
Substitutes
|
|
|
11.1
|
Plasma substitutes
|
|
|
|
Dextran 70
Dextran 40
Polygeline
|
U
U
S, T
|
|
11.2
|
Plasma Fractions
|
|
|
|
Albumin
Factor IX complex (Coagulation factors II, VII,
IX, X)*
|
S, T
T
|
|
12.
|
Cardiovascular Drugs
|
|
|
12.1
|
Anti-anginals
|
|
|
|
Diltiazem
Glyceryl Trinitrate
Isosorbide 5 Mononitrate
Propranolol
|
S, T
U
U
U
|
|
12.2
|
Antidysarhythmic drugs
|
|
|
|
Amiodarone
Diltiazem
Diltiazem*
Ligncocaine
Isoprenaline
Mexiletine
Procainamide
Quinidine
Verapamil
|
S, T
S, T
T
S, T
S, T
S, T
S, T
S, T
|
|
12.3
|
Antihypertensive
|
|
|
|
Amlodipine
Atenolol
Enalapril
Lisinopril
Terazocin
Chlothalidone
Methyldopa
Nifedipine
Propranolol
Sodium Nitroprusside*
|
S, T
U
U
U
T
U
U
S, T
U
T
|
|
12.4
|
Cardiac glycosides
|
|
|
|
Digoxin
Captopril
|
S, T
S, T
|
|
12.5
|
Vascular shock drugs
|
|
|
|
Dopamine
Dobutamine*
|
S, T
S, T
|
|
12.6
|
Antithrombotic drugs
|
|
|
|
Acetyl Salicylic Acid
Urokinase*
Streptokinase*
|
U
T
T
|
|
13.
|
Dermatological (Topical)
|
|
|
13.1
|
Antifungal Drugs
|
|
|
|
Benzoic Acid+ Salicylic Acid
Miconazole
|
U
U
|
|
13.2
|
Anti-infective drugs
|
|
|
|
Flumycetin Sulfate
Methylrosanilinium Chloride (Gentian Violet)
Neomycin+ Bacitracin
Povidone Iodine
Silver Nitrate
Silver Sulphadiazine
alcovir
|
U
U
U
U
U
U
S, T
|
|
13.3
|
Anti-inflammatory and
Anti-pruritic drugs
|
|
|
Betamethasone
Calamine
|
S, T
U
|
|
13.4
|
Keratoplastic and Keratolytic
drugs
|
|
|
|
Coal Tar
Dithranol*
Glycerine IP
Salicylic Acid
|
U
T
U
U
|
|
13.5
|
Scabicides and Pediculocides
|
|
|
|
Benzyl Benzoate
Gamma Benzene Hexachloride
|
U
U
|
|
14.
|
Diagnostic Agents
|
|
|
14.1
|
Opthalmic drugs
|
|
|
|
Fluorescein
Tropicamide
|
S, T
S, T
|
|
14.2
|
Radiocontrast media
|
|
|
|
Barium Sulphate
Sodium + Meglumine Diatrizoate
Iopanoic Acid
Meglumine lothalamate
Sodium Lothalamate
Meglumine lotroxate
Lohexol
|
S, T
S, T
S, T
S, T
S, T
S, T
T
|
|
15.
|
Disinfectants and Antiseptics
|
|
|
15.1
|
Antiseptics
|
|
|
|
Chlorhexidine
Cetrimide
Hydrogen Peroxide
Polyvidone Peroxide
Ethyl Alcohol 70%
Benzoin Compound
Gentian Violet
Acriflavin + Glycerine
|
U
U
U
U
U
U
U
U
|
|
15.2
|
Disinfectants
|
|
|
|
Bleaching Power
Formaldehyde IP*
Glutaraldehyde Alkaline
Potassium Permanganate
Chloroxylenol
Sodium Hypochloride
|
U
U
S, T
U
U
U
|
|
16.
|
Diuretics
|
|
|
|
Frusemide
Hydrochlorothiazide
Mannitol*
Spironolactone
Annoiride
|
U
U
S, T
S, T
S, T
|
|
17.
|
Gastrointestinal Drugs
|
|
|
17.1
|
Antacids and Anti Ulcer Drugs
|
|
|
|
Aluminum Hydroxide +
Magnesium Hydroxide
Ranitidine HCL
Famotidine
Omeprazole
|
U
U
S, T
S, T
|
|
17.2
|
Anti Emetics
|
|
|
|
Metoclopramide
Prochlorperazine
Promethazine
|
U
U
U
|
|
17.3
|
Anti-haemorrhoidal drugs
|
|
|
|
Local anaesthetic. Astringent
and anti-inflammatory drugs, e.g. Lidocaine/
Cinchocaine-
|
|
|
Hydorcortisone
|
U
|
|
17.4
|
Anti Inflammatory Drugs
|
|
|
|
Dulfasalazine
|
T
|
|
17.5
|
Anti Spasmodic drugs
|
|
|
|
Dicyclomine HCL
Hyoscine X Butylbromide
|
U
U
|
|
17.6
|
Cathartics
|
|
|
|
Bisacodyl
Isphagula
|
U
U
|
|
17.7
|
Drugs for Diarrhoea
|
|
|
|
Furazolidone
Loperamide* (contraindicated for pediatric use)
Oral Rehydration Salts
|
S, T
S, T
U
|
|
18.
|
Hormones, other Endocrine
Drugs and Contraceptives
|
|
18.1
|
Adrenal, Hormones and
Synthetic Analogues
|
|
|
Dexamethasone
Hydrocortisome
Methylprednisolone
Prednisolone*
|
S, T
S, T
S, T
U
|
|
18.2
|
Androgens
|
|
|
|
Testosterone Propionate*
|
S, T
|
|
18.3
|
Contraceptives
|
|
|
|
Condoms with or without
Spermicide
IUD containing Copper
Centchroman
Ethinylestradiol + Norethisterone
Ethinylestradiol + Norethisterone
Ethinylestradiol + Levonorgestrel
|
U
U
U
U
U
U
|
|
18.4
|
Estrogens
|
|
|
|
Ethinylestradiol
|
U
|
|
18.5
|
Insulins and Anti Diabetics
|
|
|
|
Glibenclamide
Insulin injection (Soluble)
Intermediate acting insulin (Lente/NPH insulin)
Metformin
|
U
U
U
U
|
|
18.6
|
Progestrogens
|
|
|
|
Norethisterone
|
U
|
|
18.7
|
Thyroid and Antithyroid
|
|
|
|
Carbimazole
Levothyroxine
Potassium Iodide
|
S, T
S, T
S, T
|
|
19.
|
Immunologicals
|
|
|
19.1
|
Diagnostic agents
|
|
|
|
Tuberculin, purified protein
derivative
|
U
|
|
19.2
|
Sera and Immunoglobulins
|
|
|
|
Anti-Snake venom
Anti-D Immunoglobulins (Human)
Anti-Tetanus Human
Immunoglobin
Diptheria Antitoxin
Rabies Immunoglobulin
|
U
S, T
S, T
S, T
S, T
|
|
19.3
|
Vaccines
|
|
|
|
B.C.G. Vaccine
D.P.T. Vaccine
Hepatitis B Vaccine
Measles Vaccine
Oral Poliomyelitis Vaccine (Live Attenuated)
Rabies Vaccine
Tetanus Toxoid
|
U
U
U
U
U
U
U
|
|
20.
|
Muscle Relaxants
(Peripherally Acting) and Cholinesterase
Inhibitors
|
|
|
Atracurium*
Vecuronium
Neostigmine
Pancuronium
Succinyl Choline
|
S, T
T
S, T
S, T
S, T
|
|
21.
|
ENT and Opthalmological
Preparations
|
|
|
21.1
|
Anti Infective
|
|
|
|
Chloramphenicol
Ciprofloxacin
Gentamycin
Sulphacetamide
Tetracycline
Framycetin
Miconazole
Fluconazole
Acyclovir
|
U
S, T
U
U
U
U
U
T
T
|
|
21.2
|
Anti Inflammatory drugs
|
|
|
|
Prednisolone
Xylometazoline
Flurbiprofen
Disodium Chromoglycate
|
U
U
S, T
S, T
|
|
21.3
|
Local Ana esthetics
|
|
|
|
Tetracaine
Xylocaine
|
U
U
|
|
21.4
|
Miotics and Antiglaucoma
drugs
|
|
|
|
Acetazolamide
Pilocarpine
Timolol Tropicamide
|
S, T
S, T
S, T
|
|
21.5
|
Mydriatics
|
|
|
|
Atropine
Homatropine
Phenylephrine
Tropicamide
|
U
U
U
S, T
|
|
22.
|
Oxytocics and Antioxytocics
|
|
|
22.1
|
Oxytocics
|
|
|
|
Methyl Ergometrine
Oxytocin
|
U
S, T
|
|
22.2
|
Antioxytocics
|
|
|
|
Terbutaline
Isoxsuprine
|
S, T
S, T
|
|
23.
|
Peritoneal Dialysis Solutions
|
|
|
|
Intraperitoneal Dialysis
Solution
|
|
|
24
|
Psychotherapeutics
|
|
|
24.1
|
Drugs used in Psychotic
disorders
|
|
|
|
Chlorpromazine
Haloperidol
Trifluoperazine
Risperidone
Pimozide
|
U
S, T
U
S, T
S, T
|
|
24.2
|
Drugs used in Mood Disorders
|
|
|
|
Imipramine
Amitryptiline
Fluoxetine*
Lithium Carbonate
|
U
S, T
S, T
S, T
|
|
24.3
|
Drugs used for Sedation an
Generalized Anxiety Disorders
|
|
|
Diazepam
Alprazolam
Chlordiazepoxide
|
U
S, T
S, T
|
|
24.4
|
Drugs for Obsessive
Compulsive Disorders and Panic Attacks
|
|
|
Clomipramine*
|
U
|
|
24.5
|
Drugs used for Dead diction
|
|
|
|
Clonidine
|
T
|
|
24.6
|
Depot Antipsychotics
|
|
|
|
Fluphenazine Deconate
|
S, T
|
|
25.
|
Drugs Acting on the
Respiratory Tract
|
|
|
25.1
|
Antiasthmatic
|
|
|
|
Theophylline Compounds
Aminophylline
Etophylline-Theophylline
Beclomethasone
Salbutamol
Ipratropium Bromide
|
P, S
U
P
U
U
T
|
|
25.2
|
Antitussives
|
|
|
|
Dextromethorphan
Codeine
|
U
S, T
|
|
26.
|
Solutions Correcting Water,
Electrolyte and Base Disturbances
|
|
26.1
|
Oral
|
|
|
|
Oral Rehydration Salts
|
U
|
|
26.2
|
Parenteral
|
|
|
|
Glucose
Glucose with Sodium Chloride
Ringer Lactate
Normal Saline
|
U
U
U
U
|
|
26.3
|
Miscellaneous
|
|
|
|
Water for Inj. IP
|
U
|
|
27
|
Vitamins and Minerals
|
|
|
|
Ascorbic Acid
Concentrated Vitamin A Solution
Nicotinamide
Pyridoxine
Retinol
Thiamine
Vitamin B Complex with Multivitamins
Vitamin D3 Ergocalciferol
Calcium Salts
|
U
U
U
U
U
U
U
S, T
U
|
|
